Category: Hepatitis

New Hepatitis C Drugs Might Eliminate the Disease

… published online March 20 in the Annals of Internal Medicine . But scientists at the U.S. National Institutes of Health caution that the new treatments fall short of a “cure.” “Hepatitis C is down but not out,” Drs. Jay Hoofnagle and Averell Sherker …

Scientists make big progress towards building complex artificial life

In a package of seven papers published Thursday in the U.S. journal Science, researchers from the Synthetic Yeast Genome Project announced that they have successfully synthesized five new yeast chromosomes, meaning that 30 percent of a key organism’s genetic material has now been swapped out for engineered replacements. By the end of this year, this international consortium, led by geneticist Jef Boeke of the New York University, hoped to have designed and built synthetic versions of all 16 chromosomes, the structures that contain DNA, for the one-celled microorganism, Baker’s yeast.

UPDF official decries poor access to Hepatitis B drugs

Lira. A senior UPDF official has observed that the government is losing the battle against Hepatitis B because people in remote areas do not have access to Hepatitis B services. Col Dr Ambrose Olko, the UPDF health programme operation commander, said people who live in rural and remote parts of the country access the least number of health services, despite being in dire need.

Hepatitis C testing unnecessary for most patients

Dear Doctor: My doctor recommends that I be tested for hepatitis C, and I’ve also seen commercials urging people to get tested for the virus – but I have no risk factors. Is it really necessary to get tested for it? Dear Reader: The majority of people who become acutely infected with hepatitis C will not have any symptoms.

Report: Patients should know about unsterile surgical tools

The state health department says SageWest hospital in Lander should inform patients who had surgery between December 2013 and October 2016 that they could have been exposed to non-sterile surgical instruments. The Casper Star-Tribune reports officials with the Wyoming Department of Health say surgeons on several occasions found dried blood and “bone-like fragments” on instruments that were supposed to be sterile.

N.H. House committee says Hepatitis B vaccine shouldn’t be required to attend school NEW

Hepatitis B and other diseases deemed “non-communicable in a child care or school setting” would be removed from the list of vaccines required by the state under a bill that got a surprise boost Wednesday from a House committee. The bill, passed by the House Health, Human Services and Elderly Affairs Committee on a 9-8 vote, says the vaccines cannot be required for enrollment in public school or child care facilities.

New hepatitis C infections among HIV-positive gay men drop by half…

New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already seen a dramatic decline in acute hepatitis C virus infections among one at-risk population, HIV-positive men who have sex with men. These findings were reported on Thursday at the Conference on Retroviruses and Opportunistic Infections in Seattle, in a session that also included presentations on rising incidence of HCV infection among HIV-positive gay men in San Diego and predictions about eradication of HIV/HCV co-infection in France.

Antiviral Therapeutics Technologies, Markets and Companies Report…

Dublin, Feb. 21, 2017 — Research and Markets has announced the addition of Jain PharmaBiotech’s new report “Antiviral Therapeutics – Technologies, Markets and Companies” to their offering. This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics.

Clarksburg-Harrison Health Official: Other states should take note of WV’s opioid struggles

The Executive Director of the Harrison-Clarksburg Health Department said there’s mostly bad news – although some good news-regarding the opioid epidemic in West Virginia and how it relates to the rest of the country. “Unfortunately in Harrison County, we have higher data showing us in the southern coal belt,” Joseph C. Bundy, formerly the President of the West Virginia Association of Local Health Departments, said Thursday.

Important Shareholder Alert: Khang & Khang LLP Announces an…

Khang & Khang LLP announces that it is investigating claims against Regulus Therapeutics Inc. concerning possible violations of federal securities laws. If you purchased shares of Regulus, and want more information free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, On June 27, 2016, the Company confirmed that it was contacted by the U.S. Food and Drug Administraion that its new drug to treat the chronic hepatitis C virus infection will be put on clinical hold due to a second incidence of jaundice.

A little-known horror

Q fever is a disease some may think is a myth, but can have serious consequences for farmers or others who work with animals. COMING TOGETHER: Health and lands service members at a meeting in Bega to discuss Q fever are David Clarke, Konrad Reardon, Peter Alexander, Duncan McKinnon, Lisa Stephenson, Helen Schaefer and Jen Manyweathers.

Hepatitis B can be acquired at age 5′

Members of the Ghana Association for the Study of Liver and Digestive Diseases are advocating a nationwide campaign to increase public awareness on Hepatitis. Interacting with TV3 after a one-day training workshop for health experts on the hepatitis B, the national president of the association, Dr Mary Yeboah Afihene, said only a few of the estimated 10-15 percent of Ghanaian adults with chronic hepatitis are aware of their condition.

Newer Hepatitis C Drugs May Pose Health Risks

Jan. 25, 2017 — Newer drugs to cure hepatitis C may put patients at risk for liver failure and other severe side effects, according to a new study from a U.S. nonprofit group that examines drug safety. The study by the Institute for Safe Medication Practices is based on an analysis of U.S. Food and Drug Administration data and reports from doctors worldwide on adverse events possibly caused by the nine widely used antiviral drugs, The New York Times reported.

Health Highlights: Jan. 25, 2017

Newer drugs to cure hepatitis C may put patients at risk for liver failure and other severe side effects, according to a new study from a U.S. nonprofit group that examines drug safety. The study by the Institute for Safe Medication Practices is based on an analysis of U.S. Food and Drug Administration data and reports from doctors worldwide on adverse events possibly caused by the nine widely used antiviral drugs, The New York Times reported.

Georgia State University, GeoVax join forces to advance development…

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections. The Centers for Disease Control and Prevention estimates between 700,000 to 1.4 million people in the United States have chronic Hepatitis B virus infections, with an estimated 20,000 new infections every year.

Hepatitis C Therapeutic and Drug Pipeline Review H2

PUNE, INDIA, January 4, 2017 / EINPresswire.com / — GET SAMPLE REPORT @ Summary Hepatitis C is a blood-borne viral infection characterized by chronic inflammation of the liver. Although patients may be asymptomatic for a number of years or decades, chronic HCV infection can lead to liver fibrosis and ultimately liver cirrhosis, in which permanent fibrotic scar tissue replaces healthy liver cells.

ContraVir expands mid-stage study of tenofovir prodrug analog into higher dose

ContraVir Pharmaceuticals broadens its ongoing Phase 2a study evaluating tenofovir exalidex against Gilead Sciences’ tenofovir disoproxil fumarate in patients with chronic hepatitis B virus infection by increasing the highest planned dose to 150 mg/day from 100 mg/day. The 84-subject sequential dose escalation study is assessing once-daily doses of TXL for four weeks against 300 mg of TDF once daily.

Hepatitis C is commonly spread by sharing needles and can hide for years without producing symptoms

HEPATITIS C remains a ‘major public health problem’ in the North West with more than 1,400 people infected in Bolton. According to Public Health England’s latest figures, it is estimated that 2,063 people in Bolton have been infected with Hep C. A proportion clear the infection themselves but the latest figures, collated in 2014, show 1,423 still had the infection and 388 received treatment.

BRIEF-JVM to buy back shares at 2 bln won

Gilead says Japan’s Ministry of Health, Labour and Welfare approves co’s Vemlidy for patients with chronic Hepatitis B virus infection * Gilead – Japan’s Ministry of Health, Labour and Welfare approves Gilead’s Vemlidy for patients with chronic Hepatitis B virus infection Source text for Eikon: Further company coverage:

View Press Release

A Once-Daily Treatment that Demonstrated Comparable Efficacy with Improved Renal and Bone Laboratory Safety Parameters Compared to Tenofovir Disoproxil Fumarate — )–Gilead Sciences, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved Vemlidy 25mg, a once-daily treatment for suppression of viral replication in chronic hepatitis B patients with evidence of hepatitis B virus replication and abnormal liver function. Vemlidy is a novel targeted prodrug of tenofovir that has demonstrated antiviral efficacy similar to and at a dose less than one-tenth that of tenofovir disoproxil fumarate 300mg.

Richland veteran calls for Hepatitis C awareness

Then several years later, after Valimont left Nevada for the Tri-Cities, he got a phone call that stopped him in his tracks. The Las Vegas clinic where he’d gotten the colonoscopy used poor sterilization practices, exposing Valimont and dozens of other patients to Hepatitis C. Hepatitis C can lead to long-term health problems, including liver failure and even death.